Literature DB >> 25108626

Cost-effectiveness of nurse-based case management versus usual care for elderly patients with myocardial infarction: results from the KORINNA study.

Hildegard Seidl1, Matthias Hunger, Reiner Leidl, Christa Meisinger, Rupert Wende, Bernhard Kuch, Rolf Holle.   

Abstract

OBJECTIVES: We assessed the cost-effectiveness of a case management intervention by trained nurses in elderly (≥65 years) patients with myocardial infarction from a societal perspective.
METHODS: The intervention and observation period spanned 1 year and 329 participants were enrolled. The intervention consisted of at least one home visit and quarterly telephone calls. Data on resource use and quality of life were collected quarterly. The primary measurements of effect were quality-adjusted life years (QALYs), based on the EuroQol five-dimensional questionnaire (EQ-5D-3L) health utilities from the German time trade-off. The secondary measurements were EQ-5D-3L utility values and patients' self-rated health states according to the visual analogue scale (VAS) among survivors. To estimate mean differences, a linear regression model was used for QALYs and a gamma model for costs. Health states among the survivors were analysed using linear mixed models. To assess the impact of different health state valuation methods, VAS-adjusted life years were constructed.
RESULTS: The mean difference in QALYs was small and not significant (-0.0163; CI -0.0681-0.0354, p value: 0.536, n = 297). Among survivors, EQ-5D-3L utilities showed significant improvements within 6 months in the intervention group (0.051; CI 0.0028-0.0989; p value: 0.0379, n = 280) but returned towards baseline levels by month 12. The mean improvement in self-rated health (VAS) within 1 year was significantly larger in the intervention group (+9.2, CI 4.665-13.766, p value: <0.0001, n = 266). The overall cost difference was -<euro>17.61 (CI - <euro>2,601-<euro>2,615; p value: 0.9856, n = 297). The difference in VAS-adjusted life years was 0.0378 (CI -0.0040-0.0796, p value: 0.0759, n = 297).
CONCLUSIONS: This study could not provide evidence to conclude that the case management intervention was an effective and cost-effective alternative to usual care within a time horizon of 1 year.

Entities:  

Mesh:

Year:  2014        PMID: 25108626     DOI: 10.1007/s10198-014-0623-3

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN: 1618-7598


  34 in total

1.  A systematic review of randomized trials of disease management programs in heart failure.

Authors:  F A McAlister; F M Lawson; K K Teo; P W Armstrong
Journal:  Am J Med       Date:  2001-04-01       Impact factor: 4.965

2.  Estimating mean QALYs in trial-based cost-effectiveness analysis: the importance of controlling for baseline utility.

Authors:  Andrea Manca; Neil Hawkins; Mark J Sculpher
Journal:  Health Econ       Date:  2005-05       Impact factor: 3.046

Review 3.  Good research practices for cost-effectiveness analysis alongside clinical trials: the ISPOR RCT-CEA Task Force report.

Authors:  Scott Ramsey; Richard Willke; Andrew Briggs; Ruth Brown; Martin Buxton; Anita Chawla; John Cook; Henry Glick; Bengt Liljas; Diana Petitti; Shelby Reed
Journal:  Value Health       Date:  2005 Sep-Oct       Impact factor: 5.725

Review 4.  Is there a case for using visual analogue scale valuations in cost-utility analysis?

Authors:  David Parkin; Nancy Devlin
Journal:  Health Econ       Date:  2006-07       Impact factor: 3.046

5.  Secondary prevention of atherosclerotic cardiovascular disease in older adults: a scientific statement from the American Heart Association.

Authors:  Jerome L Fleg; Daniel E Forman; Kathy Berra; Vera Bittner; James A Blumenthal; Michael A Chen; Susan Cheng; Dalane W Kitzman; Mathew S Maurer; Michael W Rich; Win-Kuang Shen; Mark A Williams; Susan J Zieman
Journal:  Circulation       Date:  2013-10-28       Impact factor: 29.690

6.  Consolidated Health Economic Evaluation Reporting Standards (CHEERS)--explanation and elaboration: a report of the ISPOR Health Economic Evaluation Publication Guidelines Good Reporting Practices Task Force.

Authors:  Don Husereau; Michael Drummond; Stavros Petrou; Chris Carswell; David Moher; Dan Greenberg; Federico Augustovski; Andrew H Briggs; Josephine Mauskopf; Elizabeth Loder
Journal:  Value Health       Date:  2013 Mar-Apr       Impact factor: 5.725

7.  Nurse-based case management for aged patients with myocardial infarction: study protocol of a randomized controlled trial.

Authors:  Inge Kirchberger; Christa Meisinger; Hildegard Seidl; Rupert Wende; Bernhard Kuch; Rolf Holle
Journal:  BMC Geriatr       Date:  2010-05-27       Impact factor: 3.921

8.  Measuring the value of older people's production: a diary study.

Authors:  Klas-Göran Sahlen; Curt Löfgren; Håkan Brodin; Lars Dahlgren; Lars Lindholm
Journal:  BMC Health Serv Res       Date:  2012-01-09       Impact factor: 2.655

9.  Cost-effectiveness of a coronary heart disease secondary prevention program in patients with myocardial infarction: results from a randomised controlled trial (ProActive Heart).

Authors:  Erika Turkstra; Anna L Hawkes; Brian Oldenburg; Paul A Scuffham
Journal:  BMC Cardiovasc Disord       Date:  2013-05-01       Impact factor: 2.298

10.  Effects of a nurse-based case management compared to usual care among aged patients with myocardial infarction: results from the randomized controlled KORINNA study.

Authors:  Christa Meisinger; Björn Stollenwerk; Inge Kirchberger; Hildegard Seidl; Rupert Wende; Bernhard Kuch; Rolf Holle
Journal:  BMC Geriatr       Date:  2013-10-29       Impact factor: 3.921

View more
  4 in total

Review 1.  Effect of Home Visits by Nurses on the Physical and Psychosocial Health of Older Adults: A Systematic Review and Meta-Analysis.

Authors:  Emine Ergin; Belgin Akin; Deniz Kocoglu-Tanyer
Journal:  Iran J Public Health       Date:  2022-04       Impact factor: 1.479

2.  Cost-effectiveness analysis of case management for optimized antithrombotic treatment in German general practices compared to usual care - results from the PICANT trial.

Authors:  Lisa R Ulrich; Juliana J Petersen; Karola Mergenthal; Andrea Berghold; Gudrun Pregartner; Rolf Holle; Andrea Siebenhofer
Journal:  Health Econ Rev       Date:  2019-02-07

3.  Health-related quality of life 1-3 years post-myocardial infarction: its impact on prognosis.

Authors:  Stuart Pocock; David B Brieger; Ruth Owen; Jiyan Chen; Mauricio G Cohen; Shaun Goodman; Christopher B Granger; José C Nicolau; Tabassome Simon; Dirk Westermann; Satoshi Yasuda; Katarina Hedman; Carl Mellström; Karolina Andersson Sundell; Richard Grieve
Journal:  Open Heart       Date:  2021-02

4.  Determinants of adherence and effects on health-related quality of life after myocardial infarction: a prospective cohort study.

Authors:  Gundula Krack; Rolf Holle; Inge Kirchberger; Bernhard Kuch; Ute Amann; Hildegard Seidl
Journal:  BMC Geriatr       Date:  2018-06-07       Impact factor: 3.921

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.